ArticleTropical medicine and health2025
Refining the prognostic understanding of recurrence in hepatic cystic echinococcosis surgery: a matters arising perspective.
Article in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This Matters Arising article provides a methodological commentary on the recent study by Rivadeneira et al. concerning the impact of hepatic cystic echinococcosis (HCE) recurrence on postoperative outcomes. While acknowledging the importance of their findings from an endemic region of Chile, we aim to critically examine key methodological aspects to clarify the independent prognostic role of recurrence. We discuss considerations including potential residual confounding from unadjusted cyst characteristics and surgical variables, the ascertainment of recurrence based on imaging, and the generalizability of the results from a high-endemicity population. The core purpose is to build upon this valuable work by proposing methodological refinements for future research. We recommend multi-center studies, standardized outcome sets, and combined follow-up protocols to precisely quantify the burden of HCE recurrence and enhance the global applicability of the findings for improved clinical guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.